Anti-tumor ribonuclease, combined with or conjugated to monoclonal antibody MRK16, overcomes multidrug resistance to vincristine in vitro and in vivo

  • Authors:
    • D Newton
    • J Pearson
    • Y Xue
    • M Smith
    • W Fogler
    • S Mikulski
    • W Alvord
    • H Kung
    • D Long
    • S Rybak
  • View Affiliations

  • Published online on: June 1, 1996     https://doi.org/10.3892/ijo.8.6.1095
  • Pages: 1095-1104
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Onconase, a ribonuclease isolated from Rana pipiens oocytes and early embryos, is a member of the RNase A superfamily. Onconase has anti-neoplastic properties both in vitro and in vivo, and is undergoing clinical evaluation. In the present study, Onconase was combined with or conjugated to MRK16, an anti-P-glycoprotein (Pgp) monoclonal antibody. The interaction of these combinations with vincristine (VCR) against parental and multidrug resistant (MDR), Pgp expressing, human colon carcinoma cells caused increased VCR cytotoxicity in vitro and enhanced survival of athymic nude mice given transplants of drug resistant HT-29(mdr1) cells in vivo. The results suggest that combination treatment with Onconase and other agents that modulate the chemosensitivity of Pgp-expressing human tumor cells has the potential to overcome MDR.

Related Articles

Journal Cover

June 1996
Volume 8 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Newton, D., Pearson, J., Xue, Y., Smith, M., Fogler, W., Mikulski, S. ... Rybak, S. (1996). Anti-tumor ribonuclease, combined with or conjugated to monoclonal antibody MRK16, overcomes multidrug resistance to vincristine in vitro and in vivo. International Journal of Oncology, 8, 1095-1104. https://doi.org/10.3892/ijo.8.6.1095
MLA
Newton, D., Pearson, J., Xue, Y., Smith, M., Fogler, W., Mikulski, S., Alvord, W., Kung, H., Long, D., Rybak, S."Anti-tumor ribonuclease, combined with or conjugated to monoclonal antibody MRK16, overcomes multidrug resistance to vincristine in vitro and in vivo". International Journal of Oncology 8.6 (1996): 1095-1104.
Chicago
Newton, D., Pearson, J., Xue, Y., Smith, M., Fogler, W., Mikulski, S., Alvord, W., Kung, H., Long, D., Rybak, S."Anti-tumor ribonuclease, combined with or conjugated to monoclonal antibody MRK16, overcomes multidrug resistance to vincristine in vitro and in vivo". International Journal of Oncology 8, no. 6 (1996): 1095-1104. https://doi.org/10.3892/ijo.8.6.1095